Outcomes of De Vega versus biodegradable ring annuloplasty in the surgical treatment of tricuspid regurgitation (mid-term results)

Heart Surg Forum. 2010 Aug;13(4):E233-7. doi: 10.1532/HSF98.20091170.

Abstract

Purpose: The aim of this study was to compare De Vega semicircular annuloplasty and a new biodegradable ring annuloplasty technique in patients requiring surgical intervention for tricuspid valve disease with concomitant disease of the mitral valve.

Methods: Between January 2004 and May 2008, 129 consecutive patients underwent annuloplasty procedures to correct tricuspid valve regurgitation during a concomitant mitral valve operation requiring replacement. Additionally, 24 patients underwent aortic valve replacement (AVR), 11 underwent coronary artery bypass grafting (CABG), 5 underwent AVR plus CABG, 3 underwent mitral valve replacement plus atrial septal defect (ASD) closure, and 2 underwent ASD closure. The patients in this study were assigned to 2 groups: Kalangos ring annuloplasty was performed in 67 patients (group 1), and De Vega semicircular annuloplasty was performed in the remaining 62 patients (group 2).

Results: Both tricuspid valve repair techniques produced a low rate of complications; however, the number of patients who developed residual tricuspid regurgitation was significantly lower in group 1.

Conclusion: The biodegradable ring annuloplasty technique may be used easily and safely in moderate and severe cases of tricuspid regurgitation; however, larger clinical series are necessary to confirm our promising results.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Absorbable Implants*
  • Adult
  • Aortic Valve / surgery
  • Blood Pressure
  • Cardiac Valve Annuloplasty / adverse effects
  • Cardiac Valve Annuloplasty / methods*
  • Coronary Artery Bypass
  • Echocardiography
  • Female
  • Follow-Up Studies
  • Heart / physiopathology
  • Heart Septal Defects, Atrial / complications
  • Heart Septal Defects, Atrial / surgery
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve Insufficiency / complications*
  • Mitral Valve Insufficiency / diagnostic imaging
  • Mitral Valve Insufficiency / physiopathology
  • Mitral Valve Insufficiency / surgery*
  • Pulmonary Artery / physiopathology
  • Recurrence
  • Stroke Volume
  • Treatment Outcome
  • Tricuspid Valve Insufficiency / complications*
  • Tricuspid Valve Insufficiency / diagnostic imaging
  • Tricuspid Valve Insufficiency / physiopathology
  • Tricuspid Valve Insufficiency / surgery*
  • Ventricular Function, Right
  • Young Adult